Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
1.547
+0.057 (3.82%)
Nov 21, 2024, 2:52 PM EST - Market open
LIXT Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 3 | 5 | 8 | 16 | 39 | 46 | |
| Market Cap Growth | -23.67% | -37.62% | -48.20% | -58.30% | -13.83% | -25.92% | |
| Enterprise Value | 5 | 4 | 5 | 14 | 42 | 46 | |
| Last Close Price | 1.49 | 2.35 | 5.09 | 11.90 | 31.70 | 40.74 | |
| PB Ratio | 3.08 | 1.32 | 1.64 | 3.41 | 7.83 | 18.70 | |
| P/TBV Ratio | - | 10.68 | 5.09 | 12.68 | 25.95 | - | |
| Quick Ratio | 4.98 | 13.39 | 13.53 | 15.92 | 23.41 | 10.98 | |
| Current Ratio | 5.13 | 13.73 | 14.05 | 16.81 | 24.15 | 11.23 | |
| Return on Equity (ROE) | -127.20% | -111.07% | -126.81% | -137.28% | -87.69% | -74.40% | |
| Return on Assets (ROA) | -71.88% | -64.47% | -74.05% | -81.39% | -51.68% | -44.41% | |
| Return on Capital (ROIC) | -79.20% | -69.46% | -79.25% | -85.70% | -54.83% | -47.45% | |
| Earnings Yield | -114.75% | -96.24% | -74.50% | -41.13% | -8.32% | -5.36% | |
| FCF Yield | -99.47% | -81.22% | -54.43% | -25.33% | -5.43% | -3.68% | |
| Buyback Yield / Dilution | -27.20% | -21.10% | -17.41% | -19.48% | -0.92% | -14.04% | |
| Total Shareholder Return | -27.20% | -21.10% | -17.41% | -19.48% | -0.92% | -14.04% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.